The Patent Finder

Terms ending in 2039

Gilead Sciences, Inc.

Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,253,524Metabolites of Bictegravir
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 10,710,986PD-1/PD-L1 Inhibitors
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 11,555,029PD-1/PD-L1 Inhibitors
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 12,338,233PD-1/PD-L1 Inhibitors
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 10,836,746Therapeutic Compounds
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 11,267,801Therapeutic Compounds
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 11,753,399Therapeutic Compounds
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 10,696,657Methods and Intermediates for Preparing Therapeutic Compounds
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 11,117,886Methods and Intermediates for Preparing Therapeutic Compounds
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 12,122,765Methods and Intermediates for Preparing Therapeutic Compounds
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
42 more term ends in 2039 · Pro
10 of 52 patents shown. Soonest term end first, then patent number.
Pro members see all 52.
Upgrade to Pro
50 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited